Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma

Original language	English
Number of pages	1
Journal	Gut
Early online date	30 Jun 2020
DOIs	https://doi.org/10.1136/gutjnl-2020-322096
Publication status	Early online date - 30 Jun 2020

ASJC Scopus subject areas

• Oncology

Access to Document

• 10.1136/gutjnl-2020-322096Licence: Unspecified

• Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma

  © 2020 Author(s) (or their employer(s)). No commercial re-use. See rights and permissions. Published by BMJ. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.

  Accepted author manuscript, 504 KBLicence: CC BY-NC

Student theses

• Understanding the DNA damage driven immune response in oesophageal adenocarcinoma: opportunities for improved stratification and treatment

  Lavery, A. (Author), Savage, K. (Supervisor), Turkington, R. (Supervisor) & Blayney, J. (Supervisor), Jul 2023

  Student thesis: Doctoral Thesis › Doctor of Philosophy

Research output

Research output per year 2019 2019 2019

• 1 Article

Research output per year

Research output per year

• Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

  Turkington, R., Knight, L., Blayney, J., Secrier, M., Douglas, R., Parkes, E., Sutton, E., Stevenson, L., McManus, D., Halliday, S., McCavigan, A., Logan, G., Walker, S., Steele, C., Perner, J., Bornscein, J., MacRae, S., Miremadi, A., McCarron, E. & McQuaid, S. & 10 others, Arthur, K., James, J., Eatock, M., O'Neill, R., Noble, F., Underwood, T., Harkin, D., Salto-Tellez, M., Fitzgerald, R. C. & Kennedy, R., 09 Mar 2019, (Early online date) In: Gut. 68, 11, p. 1918-1927 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Survival 100%
  • DNA Damage 100%
  • Esophageal Adenocarcinoma 100%
  • Chemotherapy 100%
  • Immune Response 90%
  20 Citations (Scopus)

  342 Downloads (Pure)

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Lavery, A., Blayney, J., & Turkington, R. (2020). Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma. Gut. Advance online publication. https://doi.org/10.1136/gutjnl-2020-322096

Lavery, Anita ; Blayney, Jaine ; Turkington, Richard. / Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma. In: Gut. 2020.

@article{4f5d1fa712de4131bc21beb476ba1fc4,

title = "Author{\textquoteright}s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma",

author = "Anita Lavery and Jaine Blayney and Richard Turkington",

year = "2020",

month = jun,

day = "30",

doi = "10.1136/gutjnl-2020-322096",

language = "English",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

Lavery, A, Blayney, J & Turkington, R 2020, 'Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma', Gut. https://doi.org/10.1136/gutjnl-2020-322096

Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma. / Lavery, Anita; Blayney, Jaine; Turkington, Richard.
In: Gut, 30.06.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma

AU - Lavery, Anita

AU - Blayney, Jaine

AU - Turkington, Richard

PY - 2020/6/30

Y1 - 2020/6/30

U2 - 10.1136/gutjnl-2020-322096

DO - 10.1136/gutjnl-2020-322096

M3 - Article

SN - 0017-5749

JO - Gut

JF - Gut

ER -

Lavery A, Blayney J, Turkington R. Author’s Response: The unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma. Gut. 2020 Jun 30. Epub 2020 Jun 30. doi: 10.1136/gutjnl-2020-322096